Centene appoints Leslie Norwalk to board under Politan Capital cooperation agreement

CENTENE CORP

Leslie Norwalk, former CMS Administrator and ex-Magellan Health director, elected to Centene's Board as Class II director.
Appointment fulfills cooperation agreement with Politan Capital Management LP, announced Dec. 14, 2021.
Norwalk will serve on Compliance, Environmental/Social Responsibility, and Government & Regulatory Affairs committees.
She brings expertise in government healthcare policy and biotech industry, per CEO Neidorff.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Leslie Norwalk

Director

CNC · CENTENE CORP

Effective: 2022-01-11
Filed: January 11, 2022, 6:59 PM ET

On January 11, 2022, the board of directors of the Company (the “Board”) elected Ms. Norwalk to the Board as a Class II director, with a term expiring at the Company’s 2024 annual meeting of stockholders, and appointed her to the Board’s Compliance Committee, Environmental and Social Responsibility Committee and Government and Regulatory Affairs Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Leslie Norwalk was elected as Director at CENTENE CORP.

Action: elected
Role: Director

Exact text from the filing

On January 11, 2022, the board of directors of the Company (the “Board”) elected Ms. Norwalk to the Board as a Class II director, with a term expiring at the Company’s 2024 annual meeting of stockholders, and appointed her to the Board’s Compliance Committee, Environmental and Social Responsibility Committee and Government and Regulatory Affairs Committee.

View on SEC.gov

CENTENE CORP filing history →

Source: SEC EDGAR

accession 0001071739-22-000017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.